Variant report

Variant	esv3402966
Chromosome Location	chr17:15847052-15849600
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr17:15848068-15848827	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr17:15847468-15847573	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr17:15849162-15849414	H1-hESC	embryonic stem cell:	n/a	n/a
4	BACH1	chr17:15848291-15848318	K562	blood:	n/a	n/a
5	BHLHE40	chr17:15849178-15849562	HepG2	liver:	n/a	chr17:15849301-15849317
6	BHLHE40	chr17:15848179-15849743	K562	blood:	n/a	chr17:15849301-15849317
7	CBX3	chr17:15848443-15848857	K562	blood:	n/a	n/a
8	CCNT2	chr17:15847735-15849423	K562	blood:	n/a	chr17:15848427-15848436
9	CEBPB	chr17:15848451-15848584	H1-hESC	embryonic stem cell:	n/a	n/a
10	CEBPD	chr17:15848291-15848695	HepG2	liver:	n/a	n/a
11	CHD1	chr17:15848562-15848613	H1-hESC	embryonic stem cell:	n/a	n/a
12	CHD2	chr17:15848139-15848850	K562	blood:	n/a	chr17:15848508-15848518
13	CHD2	chr17:15848027-15848238	H1-hESC	embryonic stem cell:	n/a	n/a
14	CHD2	chr17:15848482-15848570	HepG2	liver:	n/a	chr17:15848508-15848518
15	CHD2	chr17:15847541-15847723	H1-hESC	embryonic stem cell:	n/a	n/a
16	CHD2	chr17:15848472-15848888	H1-hESC	embryonic stem cell:	n/a	chr17:15848508-15848518
17	CREB1	chr17:15848348-15848879	H1-hESC	embryonic stem cell:	n/a	n/a
18	CREB1	chr17:15847691-15848952	A549	lung:	n/a	n/a
19	CREB1	chr17:15847880-15848997	HepG2	liver:	n/a	n/a
20	CTBP2	chr17:15847782-15849453	H1-hESC	embryonic stem cell:	n/a	n/a
21	CTCF	chr17:15848460-15848610	HPAF	blood vessel:	n/a	chr17:15848525-15848541
22	CTCF	chr17:15848440-15848590	AoAF	blood vessel:	n/a	chr17:15848525-15848541
23	CTCF	chr17:15848425-15848664	MCF-7	breast:	n/a	chr17:15848525-15848541
24	CTCF	chr17:15848080-15848230	AG04449	skin:	n/a	chr17:15848121-15848129
25	CTCF	chr17:15848020-15848170	GM12868	blood:	n/a	chr17:15848121-15848129
26	CTCF	chr17:15848500-15848650	GM12870	blood:	n/a	chr17:15848525-15848541
27	CTCF	chr17:15848040-15848190	GM12874	blood:	n/a	chr17:15848121-15848129
28	CTCF	chr17:15848480-15848630	SAEC	small airway:	n/a	chr17:15848525-15848541
29	CTCF	chr17:15848020-15848170	K562	blood:	n/a	chr17:15848121-15848129
30	CTCF	chr17:15848407-15848655	GM19240	blood:	n/a	chr17:15848525-15848541
31	CTCF	chr17:15848480-15848630	GM12871	blood:	n/a	chr17:15848525-15848541
32	CTCF	chr17:15848460-15848610	HepG2	liver:	n/a	chr17:15848525-15848541
33	CTCF	chr17:15848024-15848211	SK-N-SH_RA	brain:	n/a	chr17:15848121-15848129
34	CTCF	chr17:15847797-15848240	H1-hESC	embryonic stem cell:	n/a	chr17:15848121-15848129
35	CTCF	chr17:15848401-15848684	MCF-7	breast:	n/a	chr17:15848525-15848541
36	CTCF	chr17:15848040-15848190	AG09309	skin:	n/a	chr17:15848121-15848129
37	CTCF	chr17:15848335-15848737	A549	lung:	n/a	chr17:15848525-15848541
38	CTCF	chr17:15848460-15848610	GM12867	blood:	n/a	chr17:15848525-15848541
39	CTCF	chr17:15848040-15848190	GM12873	blood:	n/a	chr17:15848121-15848129
40	CTCF	chr17:15847940-15848210	HAc	cerebellar:	n/a	chr17:15848121-15848129
41	CTCF	chr17:15848448-15848664	Medullo	brain:	n/a	chr17:15848525-15848541
42	CTCF	chr17:15848418-15848671	H1-hESC	embryonic stem cell:	n/a	chr17:15848525-15848541
43	CTCF	chr17:15848406-15848666	GM13977	blood:	n/a	chr17:15848525-15848541
44	CTCF	chr17:15848040-15848190	AG09319	gingival:	n/a	chr17:15848121-15848129
45	CTCF	chr17:15848000-15848150	GM12869	blood:	n/a	chr17:15848121-15848129
46	CTCF	chr17:15848140-15848290	HCPEpiC	choroid plexus:	n/a	n/a
47	CTCF	chr17:15848480-15848630	HPAF	blood vessel:	n/a	chr17:15848525-15848541
48	CTCF	chr17:15847900-15848050	RPTEC	kidney:	n/a	n/a
49	CTCF	chr17:15848740-15848890	HPF	lung:	n/a	n/a
50	CTCF	chr17:15848375-15848724	H1-hESC	embryonic stem cell:	n/a	chr17:15848525-15848541

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:15848206-15848256	HCF	heart:	n/a
2	chr17:15848206-15848256	HCF	heart:	n/a
3	chr17:15849512-15849562	AG04450	lung:	fetal
4	chr17:15848216-15848266	HCM	heart:	n/a
5	chr17:15847412-15847462	NH-A	brain:	n/a
6	chr17:15848264-15848314	SKMC	muscle:	n/a
7	chr17:15847412-15847462	NHDF-neo	bronchial:	n/a
8	chr17:15847412-15847462	HRCEpiC	kidney:	n/a
9	chr17:15849556-15849606	MCF-7	breast:	n/a
10	chr17:15848216-15848266	AG04450	lung:	fetal
11	chr17:15848828-15848878	HRCEpiC	kidney:	n/a
12	chr17:15848110-15848160	GM12891	blood:	n/a
13	chr17:15849556-15849606	AG10803	skin:	n/a
14	chr17:15848216-15848266	GM06990	blood:	n/a
15	chr17:15848067-15848117	HepG2	liver:	n/a
16	chr17:15848828-15848878	NHDF-neo	bronchial:	n/a
17	chr17:15848221-15848271	PrEC	prostate:	n/a
18	chr17:15847977-15848027	MCF-7	breast:	n/a
19	chr17:15848067-15848117	A549	lung:	n/a
20	chr17:15847977-15848027	H1-hESC	embryonic stem cell:	embryo
21	chr17:15849556-15849606	HRPEpiC	eye:	n/a
22	chr17:15848110-15848160	HCM	heart:	n/a
23	chr17:15847412-15847462	HCT-116	colon:	n/a
24	chr17:15848253-15848303	Hepatocyte	liver:	n/a
25	chr17:15848828-15848878	ECC-1	luminal epithelium:	n/a
26	chr17:15848206-15848256	GM12892	blood:	n/a
27	chr17:15848253-15848303	RPTEC	kidney:	n/a
28	chr17:15848253-15848303	HCF	heart:	n/a
29	chr17:15847977-15848027	AG04450	lung:	fetal
30	chr17:15848216-15848266	ProgFib	skin:	n/a
31	chr17:15848264-15848314	Hela-S3	cervix:	n/a
32	chr17:15849556-15849606	HRCEpiC	kidney:	n/a
33	chr17:15848110-15848160	Jurkat	blood:	n/a
34	chr17:15848828-15848878	AG09309	skin:	n/a
35	chr17:15848067-15848117	U87	brain:	n/a
36	chr17:15848253-15848303	SK-N-MC	brain:	n/a
37	chr17:15848110-15848160	ProgFib	skin:	n/a
38	chr17:15848264-15848314	HUVEC	blood vessel:	n/a
39	chr17:15847412-15847462	PrEC	prostate:	n/a
40	chr17:15849556-15849606	ECC-1	luminal epithelium:	n/a
41	chr17:15848828-15848878	HEK293	kidney:	embryo
42	chr17:15848206-15848256	MCF-7	breast:	n/a
43	chr17:15848253-15848303	HEEpiC	esophagus:	n/a
44	chr17:15847977-15848027	U87	brain:	n/a
45	chr17:15848253-15848303	NHDF-neo	bronchial:	n/a
46	chr17:15848828-15848878	SK-N-SH_RA	brain:	n/a
47	chr17:15848072-15848122	HEK293	kidney:	embryo
48	chr17:15848072-15848122	HMEC	breast:	n/a
49	chr17:15848110-15848160	HIPEpiC	eye:	n/a
50	chr17:15849556-15849606	RPTEC	kidney:	n/a

No.	Distal block	Cell Line	Cell type
1	chr17:15848433..15851819-chr17:15861241..15867680,6	MCF-7	breast:
2	chr17:15847750..15848627-chr9:5628326..5629051,2	HCT-116	colon:
3	chr17:15842295..15844901-chr17:15846137..15847870,2	MCF-7	breast:
4	chr17:15732168..15733133-chr17:15847994..15848750,2	MCF-7	breast:
5	chr17:15845973..15849997-chr17:15902965..15906205,4	K562	blood:
6	chr17:15842605..15845101-chr17:15849558..15852028,2	K562	blood:
7	chr17:15846803..15850519-chr17:15901644..15904167,3	MCF-7	breast:
8	chr17:15848713..15850591-chr17:15862400..15865313,2	K562	blood:
9	chr17:15848046..15849969-chr17:15901406..15903295,2	MCF-7	breast:

Variant related genes	Relation type
ADORA2B	TF binding region
ADORA2B	CpG island
ENSG00000214941	chromatin interactions
ENSG00000227790	chromatin interactions
ENSG00000011295	chromatin interactions
ENSG00000107036	chromatin interactions

Extended variants
information (count: 93 )
Associated
traits (count: 127 )

Variant overlapped rSNPs/rCNVs (count:93 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs557058151	chr17:15847070-15847071	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs576426688	chr17:15847076-15847077	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs545397437	chr17:15847109-15847110	Weak transcription Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs559576124	chr17:15847201-15847202	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs554294969	chr17:15847234-15847235	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs528377639	chr17:15847319-15847320	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs546529327	chr17:15847320-15847321	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs528774469	chr17:15847340-15847341	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs147840548	chr17:15847348-15847349	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs140323520	chr17:15847354-15847355	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs572561193	chr17:15847357-15847358	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs562118243	chr17:15847359-15847360	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs531172542	chr17:15847375-15847376	Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs550789693	chr17:15847406-15847407	Bivalent Enhancer Weak transcription Enhancers Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs545942038	chr17:15847435-15847436	Bivalent Enhancer Weak transcription Enhancers Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs2779195	chr17:15847441-15847442	Bivalent Enhancer Weak transcription Enhancers Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region CpG island Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs531249062	chr17:15847492-15847493	Bivalent Enhancer Weak transcription Enhancers Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs547026668	chr17:15847505-15847506	Bivalent Enhancer Weak transcription Enhancers Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs565947714	chr17:15847573-15847574	Bivalent Enhancer Weak transcription Enhancers Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs534938396	chr17:15847599-15847600	Bivalent Enhancer Weak transcription Enhancers Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs548493023	chr17:15847626-15847627	Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs181662869	chr17:15847675-15847676	Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs2779196	chr17:15847692-15847693	Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs116555413	chr17:15847700-15847701	Bivalent Enhancer Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs386795829	chr17:15847864-15847865	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
26	rs115976677	chr17:15847865-15847866	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
27	rs144993524	chr17:15847867-15847868	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
28	rs2779197	chr17:15847883-15847884	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs114870354	chr17:15847892-15847893	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
30	rs62072054	chr17:15847905-15847906	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs575749589	chr17:15847944-15847945	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
32	rs149176241	chr17:15847952-15847953	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
33	rs564533355	chr17:15847960-15847961	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
34	rs533481102	chr17:15848090-15848091	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
35	rs145053625	chr17:15848202-15848203	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
36	rs560484964	chr17:15848228-15848229	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
37	rs79347649	chr17:15848255-15848256	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
38	rs548184733	chr17:15848291-15848292	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
39	rs188498748	chr17:15848386-15848387	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
40	rs536804422	chr17:15848406-15848407	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
41	rs550765812	chr17:15848457-15848458	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
42	rs570182138	chr17:15848540-15848541	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
43	rs567714270	chr17:15848542-15848543	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
44	rs114576804	chr17:15848546-15848547	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
45	rs372964783	chr17:15848558-15848559	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
46	rs73274391	chr17:15848598-15848599	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs55701218	chr17:15848610-15848611	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Weak transcription	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
48	rs2228101	chr17:15848637-15848638	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Weak transcription	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs143900813	chr17:15848651-15848652	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs61755963	chr17:15848666-15848667	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Weak transcription	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:127)

Disease	PMID	Source
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	17603634	CNVD
Melanoma	18172304	CNVD
Glioblastoma multiforme	19435819	CNVD
Non-small cell lung cancer	19010865	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16774939	CNVD
Hepatocellular carcinoma	18803288	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Burkitt''s lymphoma	19759907	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Acute myeloid leukemia	17237825	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Multiple myeloma	16616336	CNVD
Multiple myeloma	17550852	CNVD
Pancreatic cancer	21811587	CNVD
Autism	17322880	CNVD
Hereditary neuropathy with liability to pressure palsy	19521722	CNVD
Schizophrenia	19571808	CNVD
Schizophrenia	19955444	CNVD
Charcot-marie-tooth disease	18787571	CNVD
Breast cancer	20409316	CNVD
Autism	18414403	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Myelofibrosis	22110671	CNVD
Peripheral neuropathy	21193943	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	22958593	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Ovarian cancer	20844748	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
ovarian endometriomas	16273235	CNVD
Breast cancer	21858162	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17142309	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Autism	22102821	CNVD
Gastric cancer	18160780	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:431 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:15844200-15847600	Weak transcription	Right Atrium	heart
2	chr17:15845400-15847200	Enhancers	Primary neutrophils fromperipheralblood	blood
3	chr17:15845800-15847600	Enhancers	Primary monocytes fromperipheralblood	blood
4	chr17:15846000-15847200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
5	chr17:15846000-15848000	Enhancers	Lung	lung
6	chr17:15846200-15847200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
7	chr17:15846200-15847400	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
8	chr17:15846200-15847600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
9	chr17:15846200-15847600	Enhancers	Primary hematopoietic stem cells short term culture	blood
10	chr17:15846200-15847600	Weak transcription	NH-A	brain
11	chr17:15846200-15847800	Weak transcription	HMEC	breast
12	chr17:15846400-15847200	Enhancers	Monocytes-CD14+_RO01746	blood
13	chr17:15846400-15847400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
14	chr17:15846400-15847400	Weak transcription	NHEK	skin
15	chr17:15846400-15847600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
16	chr17:15846400-15847600	Weak transcription	Placenta Amnion	Placenta Amnion
17	chr17:15846400-15847600	Weak transcription	Spleen	Spleen
18	chr17:15846400-15847800	Weak transcription	HUVEC	blood vessel
19	chr17:15846400-15850000	Weak transcription	Hela-S3	cervix
20	chr17:15846600-15847800	Weak transcription	Primary B cells from cord blood	blood
21	chr17:15846800-15847200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
22	chr17:15847000-15847400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
23	chr17:15847000-15848000	Enhancers	Placenta	Placenta
24	chr17:15847200-15847400	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
25	chr17:15847200-15847400	Enhancers	Breast Myoepithelial Primary Cells	Breast
26	chr17:15847200-15847400	Flanking Bivalent TSS/Enh	Fetal Heart	heart
27	chr17:15847200-15847400	Flanking Bivalent TSS/Enh	Skeletal Muscle Female	skeletal muscle
28	chr17:15847200-15847600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
29	chr17:15847200-15847600	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
30	chr17:15847200-15847600	Bivalent Enhancer	Primary neutrophils fromperipheralblood	blood
31	chr17:15847200-15847600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
32	chr17:15847200-15847600	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
33	chr17:15847200-15847600	Enhancers	Pancreas	Pancrea
34	chr17:15847200-15848000	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
35	chr17:15847200-15848200	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
36	chr17:15847400-15847600	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
37	chr17:15847400-15847600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
38	chr17:15847400-15847600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
39	chr17:15847400-15847600	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
40	chr17:15847400-15847600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
41	chr17:15847400-15847600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
42	chr17:15847400-15847600	Enhancers	Brain Anterior Caudate	brain
43	chr17:15847400-15847600	Flanking Bivalent TSS/Enh	Brain Inferior Temporal Lobe	brain
44	chr17:15847400-15847600	Enhancers	Colon Smooth Muscle	Colon
45	chr17:15847400-15847600	Bivalent Enhancer	Fetal Brain Female	brain
46	chr17:15847400-15847600	Bivalent Enhancer	Fetal Heart	heart
47	chr17:15847400-15847600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
48	chr17:15847400-15847600	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
49	chr17:15847400-15847600	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
50	chr17:15847400-15847800	Bivalent Enhancer	H1 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links